Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Pien, E. Basner-Tschakarjan, Daniel Hui, Ashley Mentlik, Jonathan Finn, Nicole Hasbrouck, Shangzhen Zhou, S. Murphy, M. Maus, F. Mingozzi, J. Orange, K. High (2009)
Capsid antigen presentation flags human hepatocytes for destruction after transduction by adeno-associated viral vectors.The Journal of clinical investigation, 119 6
J. Guy, X. Qi, Francesco Pallotti, E. Schon, G. Manfredi, V. Carelli, A. Martinuzzi, W. Hauswirth, A. Lewin (2002)
Rescue of a mitochondrial deficiency causing Leber hereditary optic neuropathyAnnals of Neurology, 52
J. Guy, X. Qi, Rajeshwari Koilkonda, T. Arguello, Tsung-Han Chou, M. Ruggeri, V. Porciatti, A. Lewin, W. Hauswirth (2009)
Efficiency and safety of AAV-mediated gene delivery of the human ND4 complex I subunit in the mouse visual system.Investigative ophthalmology & visual science, 50 9
M. Kaplitt, A. Feigin, Chengke Tang, H. Fitzsimons, P. Mattis, P. Lawlor, R. Bland, D. Young, Kristin Strybing, D. Eidelberg, M. During (2007)
Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trialThe Lancet, 369
D. Mccarty, Haiyan Fu, P. Monahan, C. Toulson, C. Toulson, P. Naik, R. Samulski (2003)
Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivoGene Therapy, 10
P. Nagley, L. Farrell, D. Gearing, D. Nero, S. Meltzer, R. Devenish (1988)
Assembly of functional proton-translocating ATPase complex in yeast mitochondria with cytoplasmically synthesized subunit 8, a polypeptide normally encoded within the organelle.Proceedings of the National Academy of Sciences of the United States of America, 85 7
S. Worgall, D. Sondhi, N. Hackett, B. Kosofsky, Minal Kekatpure, N. Neyzi, J. Dyke, D. Ballon, L. Heier, B. Greenwald, P. Christos, M. Mazumdar, M. Souweidane, M. Kaplitt, R. Crystal (2008)
Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.Human gene therapy, 19 5
D. Mccarty (2008)
Self-complementary AAV vectors; advances and applications.Molecular therapy : the journal of the American Society of Gene Therapy, 16 10
D. McCarty, P. Monahan, R. Samulski (2001)
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesisGene Therapy, 8
C. Bonnet, S. Augustin, S. Ellouze, P. Bénit, A. Bouaita, P. Rustin, J. Sahel, M. Corral‐Debrinski (2008)
The optimized allotopic expression of ND1 or ND4 genes restores respiratory chain complex I activity in fibroblasts harboring mutations in these genes.Biochimica et biophysica acta, 1783 10
P. Chinnery, K. Majamaa, D. Turnbull, D. Thorburn (2006)
Treatment for mitochondrial disorders.The Cochrane database of systematic reviews, 1
D. Markusic, R. Herzog, G. Aslanidi, Brad Hoffman, Baozheng Li, Mengxin Li, G. Jayandharan, C. Ling, I. Zolotukhin, Wenqin Ma, S. Zolotukhin, A. Srivastava, Li Zhong (2010)
High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines.Molecular therapy : the journal of the American Society of Gene Therapy, 18 12
C. Manno, A. Chew, S. Hutchison, P. Larson, R. Herzog, V. Arruda, S. Tai, M. Ragni, A. Thompson, M. Ozelo, L. Couto, D. Leonard, F. Johnson, A. Mcclelland, C. Scallan, E. Skarsgard, A. Flake, M. Kay, K. High, B. Glader (2003)
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.Blood, 101 8
Li Zhong, Baozheng Li, G. Jayandharan, C. Mah, L. Govindasamy, M. Agbandje-McKenna, R. Herzog, Kirsten Aken, J. Hobbs, S. Zolotukhin, N. Muzyczka, A. Srivastava (2008)
Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression.Virology, 381 2
A. Sadun, C. Chicani, F. Ross-Cisneros, P. Barboni, M. Thoolen, W. Shrader, K. Kubis, V. Carelli, Guy Miller (2012)
Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy.Archives of neurology, 69 3
M. Ruggeri, Hassan Wehbe, S. Jiao, Giovanni Gregori, M. Jockovich, A. Hackam, Y. Duan, C. Puliafito (2007)
In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography.Investigative ophthalmology & visual science, 48 4
F. Mingozzi, M. Maus, Daniel Hui, D. Sabatino, S. Murphy, J. Rasko, M. Ragni, C. Manno, J. Sommer, Haiyan Jiang, G. Pierce, H. Ertl, K. High (2007)
CD8+ T-cell responses to adeno-associated virus capsid in humansNature Medicine, 13
W. Neupert (1997)
Protein import into mitochondria.Annual review of biochemistry, 66
X. Qi, Liang Sun, A. Lewin, W. Hauswirth, J. Guy (2007)
The mutant human ND4 subunit of complex I induces optic neuropathy in the mouse.Investigative ophthalmology & visual science, 48 1
V. Porciatti (2007)
The mouse pattern electroretinogramDocumenta Ophthalmologica, 115
Stefan Paschen, W. Neupert (2001)
Protein Import Into MitochondriaIUBMB Life, 52
B. Glick, G. Schatz (1981)
Import of proteins into mitochondria.Annual review of genetics, 25
B. Schilling, Srinivas M.M., Richard Row, J. Murray, Michael Cusack, R. Capaldi, C. Freed, K. Prasad, J. Andersen, B. Gibson (2005)
Rapid Purification and Mass Spectrometric Characterization of Mitochondrial NADH Dehydrogenase (Complex I) from Rodent Brain and a Dopaminergic Neuronal Cell Line*SMolecular & Cellular Proteomics, 4
L. Sazanov, Sew Peak-Chew, I. Fearnley, J. Walker (2000)
Resolution of the membrane domain of bovine complex I into subcomplexes: implications for the structural organization of the enzyme.Biochemistry, 39 24
M. Calvaruso, J. Smeitink, L. Nijtmans (2008)
Electrophoresis techniques to investigate defects in oxidative phosphorylation.Methods, 46 4
C. Manno, V. Arruda, G. Pierce, B. Glader, M. Ragni, J. Rasko, M. Ozelo, K. Hoots, P. Blatt, B. Konkle, M. Dake, R. Kaye, M. Razavi, A. Zajko, J. Zehnder, H. Nakai, A. Chew, D. Leonard, D. Leonard, J. Wright, R. Lessard, J. Sommer, M. Tigges, D. Sabatino, A. Luk, Haiyan Jiang, F. Mingozzi, L. Couto, H. Ertl, K. High, K. High, M. Kay (2006)
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune responseNature Medicine, 12
Kyle Smith, D. Johns, K. Heher, N. Miller (1993)
Heteroplasmy in Leber's hereditary optic neuropathy.Archives of ophthalmology, 111 11
A. Rath, M. Glibowicka, Vincent Nadeau, Gong Chen, C. Deber (2009)
Detergent binding explains anomalous SDS-PAGE migration of membrane proteinsProceedings of the National Academy of Sciences, 106
Hong Yu, Rajeshwari Koilkonda, Tsung-Han Chou, V. Porciatti, Sacide Ozdemir, V. Chiodo, S. Boye, S. Boye, W. Hauswirth, A. Lewin, J. Guy (2012)
Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber’s hereditary optic neuropathy in a mouse modelProceedings of the National Academy of Sciences, 109
V. Porciatti, M. Saleh, M. Nagaraju (2007)
The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma.Investigative ophthalmology & visual science, 48 2
Li Zhong, Baozheng Li, C. Mah, L. Govindasamy, M. Agbandje-McKenna, Mario Cooper, R. Herzog, I. Zolotukhin, K. Warrington, Kirsten Aken, J. Hobbs, S. Zolotukhin, N. Muzyczka, A. Srivastava (2008)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower dosesProceedings of the National Academy of Sciences, 105
W. Hauswirth, A. Lewin, S. Zolotukhin, N. Muzyczka (2000)
[48] Production and purification of recombinant adeno-associated virusMethods in Enzymology, 316
Rajeshwari Koilkonda, Tsung-Han Chou, V. Porciatti, W. Hauswirth, J. Guy (2010)
Induction of rapid and highly efficient expression of the human ND4 complex I subunit in the mouse visual system by self-complementary adeno-associated virus.Archives of ophthalmology, 128 7
W. Hauswirth, T. Aleman, S. Kaushal, A. Cideciyan, S. Schwartz, Lili Wang, T. Conlon, S. Boye, T. Flotte, B. Byrne, S. Jacobson (2008)
Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.Human gene therapy, 19 10
Rajeshwari Koilkonda, J. Guy (2010)
Leber's Hereditary Optic Neuropathy-Gene Therapy: From Benchtop to BedsideJournal of Ophthalmology, 2011
A. Maguire, F. Simonelli, E. Pierce, E. Pugh, F. Mingozzi, J. Bennicelli, S. Banfi, Kathleen Marshall, F. Testa, E. Surace, S. Rossi, A. Lyubarsky, V. Arruda, B. Konkle, E. Stone, Junwei Sun, J. Jacobs, L. Dell’Osso, R. Hertle, Jian-xing Ma, T Redmond, Xiaosong Zhu, B. Hauck, O. Zelenaia, K. Shindler, M. Maguire, J. Wright, N. Volpe, J. McDonnell, A. Auricchio, K. High, J. Bennett (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis.The New England journal of medicine, 358 21
B. Lam, W. Feuer, F. Abukhalil, V. Porciatti, W. Hauswirth, J. Guy (2010)
Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1.Archives of ophthalmology, 128 9
T. Leber (1871)
Ueber hereditäre und congenital-angelegte SehnervenleidenAlbrecht von Graefes Archiv für Ophthalmologie, 17
T. Maclachlan, M. Lukason, Margaret Collins, R. Munger, Elisabete Isenberger, C. Rogers, S. Malatos, Elizabeth Dufresne, James Morris, R. Calcedo, G. Veres, A. Scaria, L. Andrews, S. Wadsworth (2011)
Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration.Molecular therapy : the journal of the American Society of Gene Therapy, 19 2
T. Klopstock, P. Yu-Wai-Man, K. Dimitriadis, J. Rouleau, Suzette Heck, Maura Bailie, A. Atawan, Sandip Chattopadhyay, M. Schubert, Aylin Garip, M. Kernt, D. Petraki, C. Rummey, M. Leinonen, G. Metz, P. Griffiths, T. Meier, P. Chinnery (2011)
A randomized placebo-controlled trial of idebenone in Leber’s hereditary optic neuropathyBrain, 134
T. Flotte, M. Brantly, Spencer Lt, B. Byrne, C. Spencer, D. Baker, M. Humphries (2004)
Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults.Human gene therapy, 15 1
AK Zaiss, DA Muruve (2008)
Immunity to adeno-associated virus vectors in animals and humans: a continued challengeGene Therapy, 15
W. Hauswirth, A. Lewin, S. Zolotukhin, N. Muzyczka (2000)
Production and purification of recombinant adeno-associated virus.Methods in enzymology, 316
Carmen Peden, Corinna Burger, N. Muzyczka, R. Mandel (2004)
Circulating Anti-Wild-Type Adeno-Associated Virus Type 2 (AAV2) Antibodies Inhibit Recombinant AAV2 (rAAV2)-Mediated, but Not rAAV5-Mediated, Gene Transfer in the BrainJournal of Virology, 78
T. Flotte (1999)
Gene therapy for cystic fibrosis.Current opinion in molecular therapeutics, 1 4
R. Mandel, F. Manfredsson, K. Foust, Aaron Rising, S. Reimsnider, K. Nash, Corinna Burger (2006)
Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.Molecular therapy : the journal of the American Society of Gene Therapy, 13 3
P. Yu-Wai-Man, P. Griffiths, P. Chinnery (2011)
Mitochondrial optic neuropathies – Disease mechanisms and therapeutic strategiesProgress in Retinal and Eye Research, 30
G. Manfredi, Jin Fu, J. Ojaimi, J. Sadlock, J. Kwong, J. Guy, E. Schon (2002)
Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleusNature Genetics, 30
TR Flotte, BL Laube (2001)
Gene therapy in cystic fibrosis., 120
R. Gray, R. Law, R. Devenish, P. Nagley (1996)
Allotopic expression of mitochondrial ATP synthase genes in nucleus of Saccharomyces cerevisiae.Methods in enzymology, 264
Rajeshwari Koilkonda, W. Hauswirth, J. Guy (2009)
Efficient expression of self-complementary AAV in ganglion cells of the ex vivo primate retinaMolecular Vision, 15
J. Bainbridge, Alexander Smith, Susie Barker, S. Robbie, R. Henderson, K. Balaggan, A. Viswanathan, G. Holder, A. Stockman, N. Tyler, S. Petersen-Jones, S. Bhattacharya, A. Thrasher, F. Fitzke, B. Carter, G. Rubin, A. Moore, R. Ali (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis.The New England journal of medicine, 358 21
ImportanceWe developed a novel strategy for treatment of Leber hereditary optic neuropathy (LHON) caused by a mutation in the nicotinamide adenine dinucleotide dehydrogenase subunit IV (ND4) mitochondrial gene. ObjectiveTo demonstrate the safety and effects of the gene therapy vector to be used in a proposed gene therapy clinical trial. Design and SettingIn a series of laboratory experiments, we modified the mitochondrial ND4 subunit of complex I in the nuclear genetic code for import into mitochondria. The protein was targeted into the organelle by agency of a targeting sequence (allotopic expression). The gene was packaged into adeno-associated viral vectors and then vitreally injected into rodent, nonhuman primate, and ex vivo human eyes that underwent testing for expression and integration by immunohistochemical analysis and blue native polyacrylamide gel electrophoresis. During serial follow-up, the animal eyes underwent fundus photography, optical coherence tomography, and multifocal or pattern electroretinography. We tested for rescue of visual loss in rodent eyes also injected with a mutant G11778A ND4 homologue responsible for most cases of LHON. ExposureOcular infection with recombinant adeno-associated viral vectors containing a wild-type allotopic human ND4 gene. Main Outcomes and MeasuresExpression of human ND4 and rescue of optic neuropathy induced by mutant human ND4. ResultsWe found human ND4 expressed in almost all mouse retinal ganglion cells by 1 week after injection and ND4 integrated into the mouse complex I. In rodent eyes also injected with a mutant allotopic ND4, wild-type allotopic ND4 prevented defective adenosine triphosphate synthesis, suppressed visual loss, reduced apoptosis of retinal ganglion cells, and prevented demise of axons in the optic nerve. Injection of ND4 in the ex vivo human eye resulted in expression in most retinal ganglion cells. Primates undergoing vitreal injection with the ND4 test article and followed up for 3 months had no serious adverse reactions. Conclusions and RelevanceExpression of our allotopic ND4 vector in the ex vivo human eye, safety of the test article, rescue of the LHON mouse model, and the severe irreversible loss of visual function in LHON support clinical testing with mutated G11778A mitochondrial DNA in our patients.
JAMA Ophthalmology – American Medical Association
Published: Apr 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.